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Dear Readers, 
Oral cancer comprises a major clinical challenge in 
Oral Sciences fields, and in this issue of the Journal of 
Applied Oral Science, we are glad to present examples 
of bench to bedside continuous effort towards better 
diagnostic, treatment and prognostic tools to improve the 
clinical management of oral cancer.
Starting at the bedside end, MENEZES, et al.1 (2013) 
describe a rare case of mandibular bone metastasis 
derived from a tumoral prostate adenocarcinoma. While 
oral cavity and associated tissues are uncommon 
locations for metastatic tumor spread, bone metastasis 
is even rarer. In the reported case, the authors describe 
all the sequence of clinical and radiographic examination, 
medical history investigation, bone scintilography, 
incisional biopsy and immunohistochemical analysis of 
mandibular lesions that allowed the definitive diagnosis, 
and the subsequent treatment and clinical outcome 
monitoring.
While the prostate adenocarcinoma-derived 
mandibular bone metastasis comprises an infrequent 
finding that substantiates a case report, oral squamous 
cell carcinoma (OSCC) remains as the most common 
oral neoplasm. Considering that important variations are 
described in some demographic and clinicopathological 
aspects of OSCC, a long term (8 years) analysis of more 
than 300 cases was performed in a Brazilian population, 
classically described as highly miscegenated from 
the genetic viewpoint, which contrasts with the more 
homogenous genetic profiles of the North Americans, 
Europeans and Asians cohorts used to generate the 
majority of epidemiological data related to OSCC. In this 
notable clinical and histopathological effort, PIRES, et 
al.3 (2013), characterized the OSCC occurrences at the 
Oral Pathology service of the School of Dentistry, State 
University of Rio de Janeiro, a reference center for Oral 
Pathology in Rio de Janeiro metropolitan area. Within a 
series of conclusions, the authors describe the early and 
more frequent prevalence of OSCC in males, and that the 
areas affected by OSCC, as well the degree of tumors 
differentiation, differ in males and females. 
Finally, completing the bench-bedside aspect, 
PEREIRA, et al.2 (2013) investigated the expression 
profiles of MSH2, a DNA repair protein, in head and neck 
squamous cell carcinoma (HNSCC). It is important to 
mention that OSCC is a subgroup of HNSCC. By means 
of clinical, histopathological and immunohistochemical 
analysis, the authors describe that MSH2 expression 
in HNSCC tissues was associated with increased 
overall survival of patients. In mechanistic terms, MSH2 
comprises a widely expressed DNA repair protein, being 
its inactivation associated with pathologic consequences 
on DNA. Despite the possible molecular mechanisms 
underlying the control of MSH2 expression in HNSCC 
(from mutations to epigenetic modulation), a reduced 
expression of MSH2 was associated with a poor odds 
ratio (2.943) of HNSCC prognosis. 
Therefore, the three studies mentioned are interesting 
examples of the current effort to understand and manage 
oral cavity related cancer, where clinical and laboratorial 
researchers interplay, despite the parallel or collaborative 
nature, in order to provide new information to support the 
development of better diagnostic and treatment tools and 
strategies to manage oral tumors. 
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